Europe Regenerative Medicines Market by Product (Cell-Based & Acellular Products), Therapy (Cell Therapy, Gene Therapy, Tissue Engineering), and Application (Orthopedic, Dermatology, Cardiovascular) – Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis and Forecasts (2016 to 2021)

Europe Regenerative Medicines Market by Product (Cell-Based & Acellular Products), Therapy (Cell Therapy, Gene Therapy, Tissue Engineering), and Application (Orthopedic, Dermatology, Cardiovascular) – Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis and Forecasts (2016 to 2021)

ID: 274 | Pages: 138 | September 2016 | Region: Europe


Europe regenerative medicines market is expected to reach USD 13.56 billion by 2021 from USD 5.06 billion in 2016, growing at a CAGR of 21.80% during the forecast period 2016-2021. Regenerative medicines repair, replace or regenerate human cells, tissues, or organs affected due to injury, disease, aging processes, congenital defects, and damage due to trauma. These medicines restore normal functions of cells & tissues. These medicines are available in different types such as genes, somatic cells, stem cells, and other types. Some of these medicines (such as stem cells) have the ability to proliferate, differentiate thereby restore the original structure of cells or tissues or organs. Regenerative medicines are used in varied range of degenerative disorders include cardiovascular, neurodegenerative diseases, dermatology, and orthopedic, among others. Majority of the researchers aim to focus on the development of innovative technologies to provide better regenerative medicines and effective healthcare treatment solutions to patients.

Increasing aging population, growing number of life style disorders (diabetes, obesity), rising advancements in the research & development, increasing number of people suffering from chronic disorders (such as liver diseases, blood disorders), and growing involvement of government to help research institutes for the development of regenerative medicines are driving the growth of regenerative medicines market in Europe. However, presence of uncertain regulatory guidelines and stringent ethical laws to conduct research & developments in tissue engineered products & cell-based products are restraining the growth of regenerative medicines market in Europe.

Europe regenerative medicines market is segmented based on product, therapy, and application. Based on product, the market is further sub-segmented as cell-based products and acellular products. Of these, cell-based products segment is estimated to account for larger share of Europe regenerative medicines market by product in 2016. Further, Cell-based products segment is classified as autologous and allogeneic products. Based on therapy, the market is segmented as cell therapy, gene therapy, tissue engineering, and immunotherapy. Of these, cell therapy is estimated to command the highest share of Europe regenerative medicines market by therapy in 2016.

Based on application, the market is segmented as orthopedic & musculoskeletal spine, dermatology, central nervous system, cardiovascular, oncology, diabetes, and other applications. Among these, orthopedic & musculoskeletal spine is estimated to command the largest share of Europe regenerative medicines market by application in 2016.

On the basis of geographical areas, Europe regenerative medicines market is segmented as U.K., Germany, France, Italy, and Spain.

The key players in regenerative medicines market such as, Vertex Pharmaceuticals Incorporated (U.S.), Acelity L.P. Inc. (U.S.), Celgene Corporation (U.S.), StemCells, Inc. (U.S.), Organogenesis Inc.  (U.S.), NuVasive, Inc. (U.S.), Vericel Corporation (Genzyme) (U.S.), Japan Tissue Engineering Co., Ltd. (Japan), Cytori Therapeutics Inc. (U.S.), Advantagene, Inc. (U.S.), and Mesoblast Ltd. (Australia).

 1.Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Introduction                                                               

                5.2  Product                                                       

                                5.2.1 Introduction                                           

                                5.2.2 Cell-Based Products                                            

                                                5.2.2.1 Autologous Cell-Based Products                

                                                5.2.2.2 Allogeneic Cell-Based Products                  

                                5.2.3 Acellular Products                                

                5.3 Therapy                                                       

                                5.3.1 Introduction                                           

                                5.3.2 Cell Therapy                                           

                                5.3.3 Gene Therapy                                       

                                5.3.4 Tissue Engineering                                               

                                5.3.5 Immunotherapy                                   

                5.4 Application                                                 

                                5.4.1 Introduction                                           

                                5.4.2 Orthopedic & Musculoskeletal Spine                                           

                                5.4.3 Dermatology                                          

                                5.4.4 Cardiovascular                                       

                                5.4.5 Central Nervous System                                   

                                5.4.6 Oncology                                 

                                5.4.7 Diabetes                                  

                                5.4.8 Other Applications                                               

6. Geographical Analysis                                                                              

                                6.2.1 Introduction                                           

                                6.2.2 U.K                                             

                                6.2.3 Spain                                         

                                6.2.4 Germany                                 

                                6.2.5 Italy                                            

                                6.2.6 France                                       

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Vertex Pharmaceuticals Incorporated (U.S.)                                                

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Acelity L.P. Inc. (U.S.)                                                             

                8.3 Celgene Corporation (U.S.)                                                 

                8.4 StemCells, Inc. (U.S.)                                                              

                8.5 Organogenesis Inc.  (U.S.)                                                    

                8.6 NuVasive, Inc. (U.S.)                                                              

                8.7 Vericel Corporation (Genzyme) (U.S.)                                                            

                8.8 Cytori Therapeutics Inc. (U.S.)                                                            

                8.9 Advantagene, Inc. (U.S.)                                                      

                8.10 Mesoblast Ltd. (Australia)                                                  

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Expert Opinions                                                                         

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                               

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  2. Europe Regenerative Medicines Market By Product, From 2016-2021 (USD Billion)
  3. Europe Cell-Based Products Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  4. Europe Acellular Products Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  5. Europe Regenerative Medicines Market By Therapy, From 2016-2021 (USD Billion)
  6. Europe Cell Therapy Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  7. Europe Gene Therapy Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  8. Europe Tissue Engineering Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  9. Europe Immunotherapy Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  10. Europe Regenerative Medicines Market By Application, From 2016-2021 (USD Billion)
  11. Europe Orthopedic & Musculoskeletal Spine Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  12. Europe Dermatology Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  13. Europe Cardiovascular Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  14. Europe Central Nervous System Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  15. Europe Oncology Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  16. Europe Diabetes Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  17. Europe Other Applications of Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  18. U.K Regenerative Medicines Market By Product, From 2016-2021 (USD Billion)
  19. U.K Regenerative Medicines Market By Therapy, From 2016-2021 (USD Billion)
  20. U.K Regenerative Medicines Market By Application, From 2016-2021 (USD Billion)
  21. Spain Regenerative Medicines Market By Product, From 2016-2021 (USD Billion)
  22. Spain Regenerative Medicines Market By Therapy, From 2016-2021 (USD Billion)
  23. Spain Regenerative Medicines Market By Application, From 2016-2021 (USD Billion)
  24. Germany Regenerative Medicines Market By Product, From 2016-2021 (USD Billion)
  25. Germany Regenerative Medicines Market By Therapy, From 2016-2021 (USD Billion)
  26. Germany Regenerative Medicines Market By Application, From 2016-2021 (USD Billion)
  27. Italy Regenerative Medicines Market By Product, From 2016-2021 (USD Billion)
  28. Italy Regenerative Medicines Market By Therapy, From 2016-2021 (USD Billion)
  29. Italy Regenerative Medicines Market By Application, From 2016-2021 (USD Billion)
  30. France Regenerative Medicines Market By Product, From 2016-2021 (USD Billion)
  31. France Regenerative Medicines Market By Therapy, From 2016-2021 (USD Billion)
  32. France Regenerative Medicines Market By Application, From 2016-2021 (USD Billion)
  33. Europe Cell-Based Products Regenerative Medicines Market By Type, From 2016-2021 (USD Billion)
  34. Europe Autologous Cell-Based Products Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  35. Europe Allogeneic Cell-Based Products Regenerative Medicines Market By Region, From 2016-2021 (USD Billion)
  36. U.K Cell-Based Products Regenerative Medicines Market By Type, From 2016-2021 (USD Billion)
  37. Spain Cell-Based Products Regenerative Medicines Market By Type, From 2016-2021 (USD Billion)
  38. Germany Cell-Based Products Regenerative Medicines Market By Type, From 2016-2021 (USD Billion)
  39. Italy Cell-Based Products Regenerative Medicines Market By Type, From 2016-2021 (USD Billion)
  40. France Cell-Based Products Regenerative Medicines Market By Type, From 2016-2021 (USD Billion)
Middle East And Africa Industrial Alcohol Market By Type (Ethyl, Methyl, Isopropyl, Isobutyl, Benzyl Alcohol), By Source (Sugar & Molasses, Corn, Grains, Fossil Fuels), By Application (Personal Care, Pharmaceutical,...
Latin America Industrial Alcohol Market By Type (Ethyl, Methyl, Isopropyl, Isobutyl, Benzyl Alcohol), By Source (Sugar & Molasses, Corn, Grains, Fossil Fuels), By Application (Personal Care, Pharmaceutical, Fuel, Fo...
Asia Pacific Industrial Alcohol Market By Type (Ethyl, Methyl, Isopropyl, Isobutyl, Benzyl Alcohol), By Source (Sugar & Molasses, Corn, Grains, Fossil Fuels), By Application (Personal Care, Pharmaceutical, Fuel, Foo...
Europe Industrial Alcohol Market By Type (Ethyl, Methyl, Isopropyl, Isobutyl, Benzyl Alcohol), By Source (Sugar & Molasses, Corn, Grains, Fossil Fuels), By Application (Personal Care, Pharmaceutical, Fuel, Food, Che...
North America Industrial Alcohol Market By Type (Ethyl, Methyl, Isopropyl, Isobutyl, Benzyl Alcohol), By Source (Sugar & Molasses, Corn, Grains, Fossil Fuels), By Application (Personal Care, Pharmaceutical, Fuel, Fo...
Industrial Alcohol Market By Type (Ethyl, Methyl, Isopropyl, Isobutyl, Benzyl Alcohol), By Source (Sugar & Molasses, Corn, Grains, Fossil Fuels), By Application (Personal Care, Pharmaceutical, Fuel, Food, Chemical) ...
Middle East And Africa Protein Hydrolysis Enzyme Market By Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry And Others) And By End User And By Region - Indu...
Latin America Protein Hydrolysis Enzyme Market By Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry And Others) And By End User And By Region - Industry Anal...
Asia Pacific Protein Hydrolysis Enzyme Market By Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry And Others) And By End User And By Region - Industry Analy...
Europe Protein Hydrolysis Enzyme Market By Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry And Others) And By End User And By Region - Industry Analysis, S...
North America Protein Hydrolysis Enzyme Market By Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry And Others) And By End User And By Region - Industry Anal...
Protein Hydrolysis Enzyme Market By Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry And Others) And By End User And By Region - Global Industry Analysis, S...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.